
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZFP101 CRISPR/Cas9 KO Plasmid (m) | sc-423758 | 20 µg | $397.00 |
Mouse Zfp101 encodes ZFP101, a predicted C2H2-type zinc finger protein implicated in sequence-specific DNA binding and transcriptional regulation. As a putative nuclear factor, ZFP101 may contribute to chromatin-associated control of gene expression programs that coordinate cell state transitions such as proliferation, differentiation, and stress-responsive transcription. Perturbation of zinc finger–mediated regulatory networks is broadly relevant to mechanisms underlying developmental phenotypes and dysregulated transcription observed in complex diseases, including cancer and neurodevelopmental disorders. Zfp101 therefore serves as a useful locus for interrogating how transcriptional repressors/activators shape downstream signaling and genome-wide expression patterns in mouse model systems.
ZFP101 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Zfp101 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Zfp101 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Zfp101 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ZFP101 protein expression.
This CRISPR knockout system enables efficient generation of Zfp101-deficient cell models for investigation of ZFP101 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.